Navigation Links
Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities

NEW YORK, Dec. 8 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Bulk Paclitaxel - A Global Update of Market Trends & Opportunities

World bulk paclitaxel market stands enthused by the effervescent levels of research and development. With market participants injecting resources into developing unique paclitaxel formulations, emergence of new disease indications is expected to result in expanded market opportunities in the medium to long run. For instance, development of paclitaxel-coated coronary stents will help further improve the use and sales of paclitaxel. With patent expiries leading to the influx of generic forms of paclitaxel, competition is expected to intensify and result in price reductions.

These and other market data and trends are presented in "Bulk Paclitaxel: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.




Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3


Paclitaxel - Leading from the Front 3

US Market - Magnificently Outdistancing Others 4

Cancer Blockbusters - Facing the Brunt 4

A Sunrise Opportunity 4

BMS' Reign Comes to an End 4

Exploring New Avenues 5

Falling Prices - Boon for The Customers, Bane for The Companies 6

All the Strangle for Peanuts? 6

Factors Affecting the Market 6

Paclitaxel Versus Abraxane 7


Competitive Scenario 8

Cancer Generics - A Time for Optimism 8

The US Piazza 8



Angiotech Unfurls New Dimensions for Paclitaxel 10

Clinical Research Favors Paclitaxel for Breast Cancer Treatment 11

American BioScience' Nab Technology Unveils Higher Tissue

Penetration Potential 11

Naturol Develops Unique Extraction Technology for Producing

Paclitaxel from Canadian Yew 11

Ivax Corp.'s Xorane Revolutionizes the Delivery of Paclitaxel 12


Sonus to Merge with OncoGenex 13

Acusphere Signs Licensing Deal with Cephalon 13

Sonus Terminates TOCOSOL Paclitaxel Development Program 13

Eagle Pharmaceuticals to Develop and Market Tocosol Paclitaxel 13

Pliva Lachema Receives ANDA for Paclitaxel Injection 14

Cell Therapeutics Receives EMEA Acceptance 14

Abraxis Wins Approval for ABRAXANE in Korea 14

Boston Scientific Obtains Approval for TAXUS® Liberte® from

Health Canada 14

Cell Therapeutics Renames Xyotax as Opaxio 14

Dabur Launches Cancer Drug 14

Hospira Takes Over Mayne Pharma 14

Protherics to Acquire MacroMed 15

Abraxis Acquires Arizona Production Facility 15

Indena Inks Worldwide License Agreement with Spectrum Pharma 15

Bioxel Bags Major Paclitaxel Order 16

Bioxel Enters into Supply Agreement 16

Bioxel Bags Paclitaxel Supply Contract 16

Indena Establishes New Plant to Produce Synthetic Paclitaxel 16

Abraxis Selects Korean Green Cross to Market ABRAXANE® 17

Abraxis Grants License to Biocon for Marketing ABRAXANE® 17

Bioxel Registers Docetaxel with US FDA 17

Bayer Quashes TOCOSOL Paclitaxel License with Sonus 17

Abraxis' ABRAXANE Convinces European CHMP 18

Abraxis Receives Approval for ABRAXANE in Australia 18

Eurocor Receives CE Mark 18

SuperGen Divests Certain Drugs to Intas 18

Abraxis Plans Separation of Oncology Business 18

Dabur Introduces Nanoxel 19


Abraxis BioScience, Inc. (USA) 19

Bristol-Myers Squibb Co. (USA) 19

Hospira, Inc. (USA) 20

Indena S.p.A. (Italy) 20

OncoGenex Pharmaceuticals, Inc. (USA) 20

Teva Pharmaceuticals USA, Inc. (USA) 20



Rising Demand for Paclitaxel 23

Alarming Growth of Breast Cancer 23

Clinical Research Favors Paclitaxel for Breast Cancer Treatment 23

Paclitaxel - An Important Element 23

Corporate Talk 23

Drug-Eluting Stents - Marching Ahead 24


Europe 25

European Market Overview 25

European Market Battling Cost- Containment Woes 25

Efforts to Improve the Scenario and their Effect on

Paclitaxel Market 26

China 26

Chinese Government Strategizing to Save Paclitaxel Reserves 26


Table 1: Global Bulk Paclitaxel Market by Region for the Period

2007-2015 (Sales in Kilograms)

Table 2: Percentage Breakdown (Volume Sales) of Global Bulk

Paclitaxel Market by Region for the Years 2008 & 2012

Table 3: Global Bulk Paclitaxel Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 4: Percentage Breakdown (Dollar Sales) of Global Bulk

Paclitaxel Market by Region for the Years 2008 & 2012

Table 5: Bulk Paclitaxel Market in the US: 2007-2015 (Sales in


Table 6: Bulk Paclitaxel Market in the US: 2007-2015 (Sales

in US$ Million)

Table 7: Bulk Paclitaxel Market in Rest of World: 2007-2015

(Sales in Kilograms)

Table 8: Bulk Paclitaxel Market in Rest of World: 2007-2015

(Sales in US$ Million)


To order this report:

Pharmaceutical Industry: Bulk Paclitaxel - A Global Update of Market Trends & Opportunities

More Market Research Report

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
(Date:12/1/2015)... 1, 2015  Eyeon Therapeutics has received a ... treatments based on a charged hydrophilic polymer developed ... The product has been shown to be safe ... Mark Mitchnick , MD, CEO states, "This ... additional polymers in conjunction with a therapeutic agent.  ...
(Date:12/1/2015)... 1, 2015  Athletic apparel company Tommie ... to pay $1.35 million to settle Federal Trade ... copper-infused compression clothing would relieve severe and chronic ... diseases. Tommie Copper,s proposed ... and its founder and chairman Thomas Kallish ...
(Date:12/1/2015)... diciembre de 2015  AccuTEC Blades, una ... precisión, develó hoy un nuevo logo corporativo ... El nuevo logo destaca la experiencia de ... de productos con cuchillas donde "el borde ... --> ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... The Multiple System Atrophy Coalition has announced the launch of its MSA Can’t ... today to coincide with Giving Tuesday 2015, a global day of fundraising. , ... be productive, to do simple daily activities like walking to the mailbox and eating ...
(Date:12/1/2015)... ... December 01, 2015 , ... Royal River Natural Foods — a locally-owned, ... post-menopausal women who took the nutritional supplement creatine, along with resistance training for a ... not take creatine. , The report is part of the December 2015 issue of ...
(Date:12/1/2015)... ... 2015 , ... Baptist Medical Center Jacksonville has implanted the ... hospital in the region providing what is known as the world’s smallest pacemaker. ... revealed recently at a medical conference and published in The New England Journal ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... to continue the expansion of the company’s growing product line of food safety ... (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... the United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of ... often catastrophic contributors to diseases of the diabetic foot. The American Board ...
Breaking Medicine News(10 mins):